Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
26.79
-2.43 (-8.33%)
At close: Nov 16, 2026, 4:00 PM EST
26.78
0.00 (-0.02%)
After-hours: Nov 16, 2026, 4:04 PM EST

Viking Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-648.57-393.34-150.92-100.83-70.36-55.68
Net Income
-627.2-359.64-109.96-85.9-68.87-54.99
Earnings Per Share
-5.41-3.19-1.01-0.91-0.90-0.71
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
959.81705.74902.61362.08155.49202.1
Total Debt
254.690.141.121.261.560.03
Net Cash (Debt)
705.12705.6901.49360.82153.92202.07
Net Cash Growth
-1.22%-21.73%149.85%134.42%-23.83%-18.53%
Net Cash Per Share
6.086.268.273.822.002.62

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-462.63-278.69-87.79-73.38-48.4-47.59
Free Cash Flow
-462.63-278.69-87.79-73.38-48.4-47.59
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.